156 related articles for article (PubMed ID: 11796821)
1. Immunohistochemical detection of hypochlorite-modified proteins in glomeruli of human membranous glomerulonephritis.
Gröne HJ; Gröne EF; Malle E
Lab Invest; 2002 Jan; 82(1):5-14. PubMed ID: 11796821
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins.
Malle E; Waeg G; Schreiber R; Gröne EF; Sattler W; Gröne HJ
Eur J Biochem; 2000 Jul; 267(14):4495-503. PubMed ID: 10880973
[TBL] [Abstract][Full Text] [Related]
3. Myeloperoxidase in kidney disease.
Malle E; Buch T; Grone HJ
Kidney Int; 2003 Dec; 64(6):1956-67. PubMed ID: 14633118
[TBL] [Abstract][Full Text] [Related]
4. Immunological evidence for hypochlorite-modified proteins in human kidney.
Malle E; Woenckhaus C; Waeg G; Esterbauer H; Gröne EF; Gröne HJ
Am J Pathol; 1997 Feb; 150(2):603-15. PubMed ID: 9033274
[TBL] [Abstract][Full Text] [Related]
5. Myeloperoxidase-dependent generation of hypochlorite-modified proteins in human placental tissues during normal pregnancy.
Hammer A; Desoye G; Dohr G; Sattler W; Malle E
Lab Invest; 2001 Apr; 81(4):543-54. PubMed ID: 11304574
[TBL] [Abstract][Full Text] [Related]
6. Hypochlorite-modified (lipo)proteins are present in rabbit lesions in response to dietary cholesterol.
Malle E; Wäg G; Thiery J; Sattler W; Gröne HJ
Biochem Biophys Res Commun; 2001 Dec; 289(4):894-900. PubMed ID: 11735131
[TBL] [Abstract][Full Text] [Related]
7. Influence of native and hypochlorite-modified low-density lipoprotein on gene expression in human proximal tubular epithelium.
Porubsky S; Schmid H; Bonrouhi M; Kretzler M; Malle E; Nelson PJ; Gröne HJ
Am J Pathol; 2004 Jun; 164(6):2175-87. PubMed ID: 15161651
[TBL] [Abstract][Full Text] [Related]
8. Abnormal expression of glomerular basement membrane laminins in membranous glomerulonephritis.
Fischer E; Mougenot B; Callard P; Ronco P; Rossert J
Nephrol Dial Transplant; 2000 Dec; 15(12):1956-64. PubMed ID: 11096140
[TBL] [Abstract][Full Text] [Related]
9. Impact of MPO-ANCA-mediated oxidative imbalance on renal vasculitis.
Hilhorst M; Maria AT; Kavian N; Batteux F; Borderie D; Le Quellec A; van Paassen P; Guilpain P
Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1769-F1776. PubMed ID: 30207165
[TBL] [Abstract][Full Text] [Related]
10. Presence of hypochlorite-modified proteins in human atherosclerotic lesions.
Hazell LJ; Arnold L; Flowers D; Waeg G; Malle E; Stocker R
J Clin Invest; 1996 Mar; 97(6):1535-44. PubMed ID: 8617887
[TBL] [Abstract][Full Text] [Related]
11. Chlorination and oxidation of the extracellular matrix protein laminin and basement membrane extracts by hypochlorous acid and myeloperoxidase.
Nybo T; Dieterich S; Gamon LF; Chuang CY; Hammer A; Hoefler G; Malle E; Rogowska-Wrzesinska A; Davies MJ
Redox Biol; 2019 Jan; 20():496-513. PubMed ID: 30476874
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune kidney diseases.
Segelmark M; Hellmark T
Autoimmun Rev; 2010 Mar; 9(5):A366-71. PubMed ID: 19906361
[TBL] [Abstract][Full Text] [Related]
13. The in situ expression of interleukin-8 in the normal human kidney and in different morphological forms of glomerulonephritis.
Niemir ZI; Stein H; Ciechanowicz A; Olejniczak P; Dworacki G; Ritz E; Waldherr R; Czekalski S
Am J Kidney Dis; 2004 Jun; 43(6):983-98. PubMed ID: 15168378
[TBL] [Abstract][Full Text] [Related]
14. Mesangiocapillary glomerulonephritis type III and idiopathic membranous glomerulopathy. Morphometric comparison of the deposits and glomerular basement membrane including clinico-morphological correlations.
Danilewicz M; Wagrowska-Danilewicz M
Pol J Pathol; 1997; 48(1):43-8. PubMed ID: 9200960
[TBL] [Abstract][Full Text] [Related]
15. Resolving primary membranous glomerulopathy (MGN) reveals a dynamically metabolic pathway from sub-epithelium to glomerular basement membranes.
Al-Othman YA; Kroneman O; Kumar S; Li W; Kanaan HD; Liu ML; Qu H; Zhang PL
Ultrastruct Pathol; 2022 Jan; 46(1):122-129. PubMed ID: 35109758
[TBL] [Abstract][Full Text] [Related]
16. Immunologic detection and measurement of hypochlorite-modified LDL with specific monoclonal antibodies.
Malle E; Hazell L; Stocker R; Sattler W; Esterbauer H; Waeg G
Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):982-9. PubMed ID: 7541296
[TBL] [Abstract][Full Text] [Related]
17. [Case of MPO-ANCA-associated vasculitis with membranous nephropathy].
Watanabe S; Arimura Y; Nomura K; Kawashima S; Yoshihara K; Kaname S; Yamada A
Nihon Jinzo Gakkai Shi; 2011; 53(1):46-52. PubMed ID: 21370577
[TBL] [Abstract][Full Text] [Related]
18. Hypochlorite-modified high density lipoprotein, a high affinity ligand to scavenger receptor class B, type I, impairs high density lipoprotein-dependent selective lipid uptake and reverse cholesterol transport.
Marsche G; Hammer A; Oskolkova O; Kozarsky KF; Sattler W; Malle E
J Biol Chem; 2002 Aug; 277(35):32172-9. PubMed ID: 12070141
[TBL] [Abstract][Full Text] [Related]
19. Correlation between intima-to-media ratio, apolipoprotein B-100, myeloperoxidase, and hypochlorite-oxidized proteins in human atherosclerosis.
Hazell LJ; Baernthaler G; Stocker R
Free Radic Biol Med; 2001 Nov; 31(10):1254-62. PubMed ID: 11705704
[TBL] [Abstract][Full Text] [Related]
20. Renal participation of myeloperoxidase in antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis.
O'Sullivan KM; Lo CY; Summers SA; Elgass KD; McMillan PJ; Longano A; Ford SL; Gan PY; Kerr PG; Kitching AR; Holdsworth SR
Kidney Int; 2015 Nov; 88(5):1030-46. PubMed ID: 26176828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
